Cargando…
Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515303/ https://www.ncbi.nlm.nih.gov/pubmed/18671846 http://dx.doi.org/10.1186/1746-160X-4-17 |
_version_ | 1782158409539256320 |
---|---|
author | Driemel, Oliver Müller-Richter, Urs DA Hakim, Samer G Bauer, Richard Berndt, Alexander Kleinheinz, Johannes Reichert, Torsten E Kosmehl, Hartwig |
author_facet | Driemel, Oliver Müller-Richter, Urs DA Hakim, Samer G Bauer, Richard Berndt, Alexander Kleinheinz, Johannes Reichert, Torsten E Kosmehl, Hartwig |
author_sort | Driemel, Oliver |
collection | PubMed |
description | BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the eruptive intraoral growth-pattern, age-peak, unfavourable prognosis and slit-like intratumorous spaces in common histological staining as identical clinical and histopathological features. Immunohistochemical staining for pancytokeratin, cytokeratin, collagen type IV, γ2-chain of laminin-5, endothelial differentiation marker CD31 and CD34, F VIII-associated antigen, Ki 67-antigen, β-catenin, E-cadherin, α-smooth-muscle-actin and Fli-1 were done. RESULTS: Cytokeratin-immunoreactive cells can be identified in both lesions. The large vascularization of ASCC complicates the interpretation of vascular differential markers being characteristic for angiosarcoma. Loss of cell-cell-adhesion, monitored by loss of E-cadherin and β-catenin membrane-staining, are indetified as reasons for massive expression of invasion-factor ln-5 in ASCC and considered responsible for unfavourable prognosis of ASCC. Expression of Fli-1 in angiosarcoma and cellular immunoreaction for ln-5 in ASCC are worked out as distinguishing features of both entities. CONCLUSION: Fli-1 in angiosarcoma and ln-5 in ASCC are distinguishing features. |
format | Text |
id | pubmed-2515303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25153032008-08-13 Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma Driemel, Oliver Müller-Richter, Urs DA Hakim, Samer G Bauer, Richard Berndt, Alexander Kleinheinz, Johannes Reichert, Torsten E Kosmehl, Hartwig Head Face Med Research BACKGROUND: acantholytic squamous cell carcinomas (ASCC) and intraoral angiosarcoma share similar histopathological features. Aim of this study was to find marker for a clear distinction. METHODS: Four oral acantholytic squamous cell carcinomas and one intraoral angiosarcoma are used to compare the eruptive intraoral growth-pattern, age-peak, unfavourable prognosis and slit-like intratumorous spaces in common histological staining as identical clinical and histopathological features. Immunohistochemical staining for pancytokeratin, cytokeratin, collagen type IV, γ2-chain of laminin-5, endothelial differentiation marker CD31 and CD34, F VIII-associated antigen, Ki 67-antigen, β-catenin, E-cadherin, α-smooth-muscle-actin and Fli-1 were done. RESULTS: Cytokeratin-immunoreactive cells can be identified in both lesions. The large vascularization of ASCC complicates the interpretation of vascular differential markers being characteristic for angiosarcoma. Loss of cell-cell-adhesion, monitored by loss of E-cadherin and β-catenin membrane-staining, are indetified as reasons for massive expression of invasion-factor ln-5 in ASCC and considered responsible for unfavourable prognosis of ASCC. Expression of Fli-1 in angiosarcoma and cellular immunoreaction for ln-5 in ASCC are worked out as distinguishing features of both entities. CONCLUSION: Fli-1 in angiosarcoma and ln-5 in ASCC are distinguishing features. BioMed Central 2008-07-31 /pmc/articles/PMC2515303/ /pubmed/18671846 http://dx.doi.org/10.1186/1746-160X-4-17 Text en Copyright © 2008 Driemel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Driemel, Oliver Müller-Richter, Urs DA Hakim, Samer G Bauer, Richard Berndt, Alexander Kleinheinz, Johannes Reichert, Torsten E Kosmehl, Hartwig Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title | Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title_full | Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title_fullStr | Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title_full_unstemmed | Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title_short | Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
title_sort | oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515303/ https://www.ncbi.nlm.nih.gov/pubmed/18671846 http://dx.doi.org/10.1186/1746-160X-4-17 |
work_keys_str_mv | AT driemeloliver oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT mullerrichterursda oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT hakimsamerg oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT bauerrichard oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT berndtalexander oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT kleinheinzjohannes oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT reicherttorstene oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma AT kosmehlhartwig oralacantholyticsquamouscellcarcinomasharesclinicalandhistologicalfeatureswithangiosarcoma |